Teladoc Health Inc. (TDOC) shares plummeted 18.29% in the pre-market session on Thursday following the virtual healthcare provider's disappointing fourth-quarter 2024 earnings results and lackluster outlook for 2025.
For the fourth quarter of 2024, Teladoc reported a wider-than-expected net loss of $0.28 per share, compared to analysts' expectations of a $0.23 loss. While revenue of $640.5 million narrowly beat estimates, it declined by 3% year-over-year. The company's adjusted EBITDA also fell across its Integrated Care and BetterHelp segments.
The earnings miss was primarily driven by a 10% revenue decline in Teladoc's direct-to-consumer BetterHelp mental health segment, reflecting decreased demand for its services. The company's gross margin slipped to 65.7% from 68.8% a year earlier, further pressuring profitability.
Looking ahead, Teladoc provided 2025 revenue guidance of $2.468 billion to $2.576 billion, mostly below the $2.570 billion it reported in 2024. Its adjusted EBITDA forecast range of $278 million to $319 million is largely below the $310.7 million achieved last year.
The disappointing results and weak guidance underscore the challenges Teladoc faces in a highly competitive virtual healthcare market. While the company aims to stabilize its BetterHelp business and focus on international growth opportunities, concerns over slowing demand weighed heavily on the stock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.